The evolution opens doors for the treatment of neurotrophic keratitis and beyond.
Flavio Mantelli, MD, PhD
Advertisement
Articles by Flavio Mantelli, MD, PhD
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
Advertisement
Latest Updated Articles
Nerve growth factor: From discovery to development for human usePublished: May 9th 2023 | Updated:
Dompe's past developments, continual progress in NGF applicationsPublished: February 8th 2023 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia
2
Fitting the future: How technology is refining specialty lens care
3
Sydnexis releases phase 3 STAR trial results on SYD-101 0.01% for slowing myopia progression
4
Study examines association between air pollutants and dry eye via gene involvement
5
.png "Optometry Times"){kind=logo}
